| 注册
首页|期刊导航|中国现代医学杂志|联合监测血清AFP-L3与HBV DNA在诊断肝硬化癌变中的价值

联合监测血清AFP-L3与HBV DNA在诊断肝硬化癌变中的价值

王瑜 王志军

中国现代医学杂志2018,Vol.28Issue(7):51-54,4.
中国现代医学杂志2018,Vol.28Issue(7):51-54,4.DOI:10.3969/j.issn.1005-8982.2018.07.010

联合监测血清AFP-L3与HBV DNA在诊断肝硬化癌变中的价值

Value of combined detection of serum AFP-L3 and HBV DNA in diagnosis of hepatocellular carcinoma secondary to HBV-related cirrhosis

王瑜 1王志军2

作者信息

  • 1. 河南科技大学附属安阳市第五人民医院 检验科,河南 安阳 455001
  • 2. 河南省安阳市人民医院 普外科,河南 安阳 455000
  • 折叠

摘要

Abstract

Objective To evaluate the value of serum alpha-fetoprotein-L3 (AFP-L3) and hepatitis B virus DNA (HBV DNA) detection in diagnosis of hepatocellular carcinoma (HCC) secondary to HBV-related cirrhosis. Methods Serum samples were collected from 66 patients with HCC secondary to HBV-related cirrhosis and 71 cases with HBV-related cirrhosis. HBV DNA content was measured by real-time fluorescent quantitative polymerase chain reaction (qRT-PCR). AFP-L3 was separated by micro centrifugal purification column. The levels of AFP-L3 and total AFP were quantified by electrochemiluminescence immunoassay; the percentage of AFP-L3 to total AFP was calculated. Statistical analysis was performed using SPSS 19.0 for Windows. Results The positive rates of AFP-L3 and HBV DNA in the patients with HCC were 74.2% and 59.1% respectively, but in the patients with cirrhosis they were 9.9% and 33.8% respectively. The positive rates of AFP-L3 and HBV DNA in the patients with HCC were both higher than those in the patients with cirrhosis (χ2= 58.667 and 8.806, P = 0.000 and 0.003). The results of AFP-L3 and HBV DNA were consistent (Kappa = 0.748). In parallel diagnostic test, the sensitivity of combined detection was higher than that of AFP-L3 alone (χ2= 6.371, P = 0.012). There was no significant difference between the specificity of combined detection and that of AFP-L3 alone in the diagnosis of HCC secondary to HBV-related cirrhosis (χ2= 0.132, P = 0.716). Conclusions The results of AFP-L3 and HBV DNA are consistent to some extent, they both can be regarded as important markers of HCC. The parallel test of combining AFP-L3 and HBV DNA can improve the sensitivity for diagnosis of HCC, can effectively reduce missed diagnosis of HCC.

关键词

肝癌/肝硬化/乙型肝炎病毒DNA/甲胎蛋白异质体L3

Key words

hepatocellular carcinoma/hepatic cirrhosis/HBV DNA/AFP-L3

分类

医药卫生

引用本文复制引用

王瑜,王志军..联合监测血清AFP-L3与HBV DNA在诊断肝硬化癌变中的价值[J].中国现代医学杂志,2018,28(7):51-54,4.

中国现代医学杂志

OACSTPCD

1005-8982

访问量0
|
下载量0
段落导航相关论文